» Articles » PMID: 34277810

Collagen Sponge Prolongs Taurine Release for Improved Wound Healing Through Inflammation Inhibition and Proliferation Stimulation

Overview
Journal Ann Transl Med
Date 2021 Jul 19
PMID 34277810
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Attenuating oxidative stress response is an effective strategy for the treatment of wounds. Taurine is a widely abundant amino acid in mammal species, capable of inhibiting oxygen-free radicals during the inflammation phase.

Methods: A novel taurine carried biocompatible composite collagen-derived sponge, Tau@Col, was fabricated for the treatment of a full-thickness removal mouse wounds model. experiments included taurine release from Tau@Col and cell viability when co-cultured with Tau@Col. With the prolonged release of taurine upon the wound site, Tau@Col was engineered to perform well in the wound site through inflammation inhibition and proliferation stimulation as demonstrated by a series of histological staining.

Results: taurine release profile and good cell biocompatibility of Tau@Col were demonstrated. studies showed that Tau@Col indeed sped up the process of wound regeneration through enhanced granulation formation, collagen deposition as well as re-epithelialization. Further investigations through immunofluorescence staining revealed that the improved wound healing ability of Tau@Col was mediated by the enhanced cell proliferation via the upregulation of endogenous vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-β) expression as well as decreased inflammatory response through stimulated M2 polarization of macrophages.

Conclusions: This engineered Tau@Col delivery system has great potential as a wound dressing in future applications.

Citing Articles

Collagen-Based Nanoparticles as Drug Delivery System in Wound Healing Applications.

Kusnadi K, Herdiana Y, Rochima E, Putra O, Gazzali A, Muchtaridi M Int J Nanomedicine. 2024; 19:11321-11341.

PMID: 39524919 PMC: 11550700. DOI: 10.2147/IJN.S485588.


The role of adipose tissue-derived stromal cells, macrophages and bioscaffolds in cutaneous wound repair.

Gandolfi S, Sanouj A, Chaput B, Coste A, Sallerin B, Varin A Biol Direct. 2024; 19(1):85.

PMID: 39343924 PMC: 11439310. DOI: 10.1186/s13062-024-00534-6.


Collagen and Its Derivatives Serving Biomedical Purposes: A Review.

Wosicka-Frackowiak H, Poniedzialek K, Wozny S, Kuprianowicz M, Nyga M, Jadach B Polymers (Basel). 2024; 16(18).

PMID: 39339133 PMC: 11435467. DOI: 10.3390/polym16182668.


Clinical Study of Rh-bFGF Combined With Collagen Sponge in the Treatment of Maxillofacial Deep Ⅱ Degree Burn.

Wang Q, Yang X, Wang L, Lin T, Wei Z J Craniofac Surg. 2024; .

PMID: 38408325 PMC: 11045551. DOI: 10.1097/SCS.0000000000010023.


Use of a taurolidine containing antimicrobial wash to reduce cardiac implantable electronic device infection.

Borov S, Baldauf B, Henke J, Pavaci H, Perani A, Zrenner B Europace. 2023; 25(10).

PMID: 37831737 PMC: 10616572. DOI: 10.1093/europace/euad306.


References
1.
Apte R, Chen D, Ferrara N . VEGF in Signaling and Disease: Beyond Discovery and Development. Cell. 2019; 176(6):1248-1264. PMC: 6410740. DOI: 10.1016/j.cell.2019.01.021. View

2.
Degim Z, Celebi N, Sayan H, Babul A, Erdogan D, Take G . An investigation on skin wound healing in mice with a taurine-chitosan gel formulation. Amino Acids. 2002; 22(2):187-98. DOI: 10.1007/s007260200007. View

3.
Ungefroren H, Wellner U, Keck T, Lehnert H, Marquardt J . The Small GTPase RAC1B: A Potent Negative Regulator of-and Useful Tool to Study-TGFβ Signaling. Cancers (Basel). 2020; 12(11). PMC: 7700615. DOI: 10.3390/cancers12113475. View

4.
Hameedaldeen A, Liu J, Batres A, Graves G, Graves D . FOXO1, TGF-β regulation and wound healing. Int J Mol Sci. 2014; 15(9):16257-69. PMC: 4200873. DOI: 10.3390/ijms150916257. View

5.
Nillesen S, Geutjes P, Wismans R, Schalkwijk J, Daamen W, van Kuppevelt T . Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials. 2006; 28(6):1123-31. DOI: 10.1016/j.biomaterials.2006.10.029. View